Diagnostic Pathology · 2014 · 44 citations · 18 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyNeoplasiaCancer BiomarkersCancer Survival AnalysisCervical CancerMalignant NeoplasmsMicrorna BiologyNoncoding Rna In CancerClinicopathologic FeaturesCox RegressionKaplan-meier Confidence IntervalsKaplan-meier Survival EstimatesMicrorna BiomarkersMicrorna In CancerMicrorna Prognostic MarkersNoncoding Rna Expression Profiling
BACKGROUND: MicroRNA-126(miR-126) has been shown to be frequently down-regulated in a variety of malignancies and act as a potential tumor suppressor. However, its correlations with the clinicopathological characters of cervical cancer remain unclear. METHODS: TaqMan quantitative RT-PCR was used to determine the expression level of miR-126 in tissue samples. The associations of miR-126 expression with clinicopathologic variables were analyzed. Kaplan-Meier survival analysis was performed to analyze the association of miR-126 expression with overall survival (OS) of patients. Univariate and multivariate Cox regression analyses were performed. RESULTS: miR-126 expression level in human cervical cancer tissues was significantly lower than that in adjacent nontumorous tissues (mean ± SD: 0.59 ± 0.44 vs. 1.00 ± 0.51, P < 0.0001). Decreased miR-126 expression in cervical cancer was found to be significantly associated with lymphatic invasion (P = 0.002), distant metastasis (P < 0.001), FIGO stage (P = 0.009), and histological grade (P = 0.005). Kaplan-Meier analysis showed that patients with lower levels of miR-126 had significantly poorer survival than those with higher expression of this miRNA in patients, with a 5-year OS of 45.7% and 70.9%, respectively (P = 0.002). Multivariate analysis revealed that miR-126 expression (HR = 3.97, 95% CI: 2.01-20.22; P = 0.003) was independently associated with the OS. CONCLUSION: Our data suggests the potential of miR-126 as a prognostic biomarker for cervical cancer. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_220.
18
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology · 2015 · 5.3K citations · Full text
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie, Claudio R. Alarcón, Thórdur Óskarsson et al. · Nature · 2008 · 1.9K citations · Full text
miR-126 functions as a tumour suppressor in human gastric cancer
Runhua Feng, Xuehua Chen, Yingyan Yu et al. · Cancer Letters · 2010 · 297 citations